SAN FRANCISCO, March 31, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts PTC, Inc. (NASDAQ:PTC) investors of the May 6, 2016 lead plaintiff deadline in the securities fraud class action lawsuit related to alleged misstatements about the investigations into Company’s compliance with the Foreign Corrupt Practices Act (FCPA).
If you suffered losses because of your purchases of PTC between November 24, 2011 and July 29, 2015, or have information that will help our investigation contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing [email protected] or visiting https://www.hbsslaw.com/cases/PTC. The lawsuit was filed in the U.S. District Court for the District of Massachusetts and investors have until May 6, 2016 to move the court to participate as a lead plaintiff.
The class action complaint alleges that PTC and certain of its executives made false and misleading statements and/or failed to disclose that: (1) PTC did not inform the Securities and Exchange Commission (“SEC”) and the Department of Justice (“DOJ”) of the full results of its investigation into whether PTC China violated the Foreign Corrupt Practices Act (“FCPA”) by improperly providing recreational travel to Chinese government officials; (2) PTC was not cooperating with the SEC and DOJ in connection with their investigations into whether PTC China’s conduct violated the FCPA; (3) PTC’s books and records were inaccurate and its internal controls were ineffective; and (4) as a result, PTC’s public statements were materially false and misleading at all relevant times.
On July 29, 2015, PTC issued a press release announcing the Company recorded a $13.6 million liability associated with pending discussions with the SEC and DOJ to resolve their investigations of PTC. The Company reported that $13.6 million was the minimum amount of liability that it expected to incur if it could settle with the SEC and DOJ. Following this news, PTC’s common stock price declined $1.57 per share, or over 4%, to close on July 30, 2015 at $36.23 per share.
Whistleblowers: Persons with non-public information regarding PTC should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 



